Vazkepa Gets EMA Nod for Cardiovascular Disease, But Hurdles Remain
Last month’s EU approval of Vazkepa -- a treatment derived from fish oil and branded…
21/04/2021 - 5 minutes
Ireland
Iterum Therapeutics Reels from Antibiotic Phase III Fail
An antibiotic candidate developed by the Irish company Iterum Therapeutics has failed to meet the…
12/12/2019 - 2 minutes
Positive Phase III Results for Narcolepsy Drug with Low Cardiovascular Risk
The narcolepsy drug, developed by Irish company Jazz Pharmaceuticals, has a lower salt content than…
26/09/2019 - 2 minutes
Irish Life Sciences VC Raises €118M Fund with European Focus
Fountain Healthcare Partners has raised €118M in its third fund dedicated to investing in life…
23/05/2019 - 2 minutes
First Plant in the Works to Turn Dairy Byproducts Into Plastics
The company Glanbia Ireland is planning to construct the first industrial biorefinery that transforms dairy…
13/02/2019 - 2 minutes
Anti-Inflammatory Treatments Get €40M Boost in Series B
A Series B funding round has whipped up €40M for the Irish company Inflazome. This…
19/11/2018 - 2 minutes
Parkinson’s Disease Vaccine Shows Preclinical Promise
The biotech company United Neuroscience has developed a candidate Parkinson's disease vaccine that targets a…
14/11/2018 - 2 minutes
Nestlé and AI Biotech Hunt Down Bioactive Peptides in Our Food
Nuritas and Nestlé will use artificial intelligence to find bioactive peptides in the food we…
14/02/2018 - 3 minutes
Janssen Biotech Offers up to $1Bn to Irish Biotech for a Bowel Inflammation Drug
Janssen Biotech and Theravance Biopharma will develop together a drug to treat bowel inflammation diseases…
08/02/2018 - 2 minutes
The European Patent Office Revokes the Broad Institute‘s CRISPR Patents
The Broad Institute has been dealt a big blow in its battle for CRISPR/Cas9 intellectual…
19/01/2018 - 3 minutes
Meet the 10 Promising Synbio Startups in RebelBio’s London Cohort
Irish accelerator RebelBio has launched its latest cohort of startups that will receive its support…
18/01/2018 - 4 minutes
Allergan Takes to the Clinic a New Alzheimer’s Drug from a €3Bn Deal
Allergan's partner Heptares Therapeutics has dosed the first patient with a GPCR drug to treat…
01/09/2017 - 2 minutes
